Santhera Pharmaceuticals SANN View profile
Rare disease specialist Santhera is delivering life-changing treatment for DMD
Thursday 8 October
Today’s Edition
FIVE AT FIVE: Pennon hits shareholders for £550m, Shell upgrades and Inchcape gets the chop
Wednesday's five from The Markets
THE BREAK-DOWN: Pennon shareholders pick up the bill for a £1bn reset
Here we take a deep dive into the day's biggest business story
